Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended and Clarification given by BSE vide Circular no. LIST/COMP/01/2019-20 dated 02 April 2019 and pursuant to the Company’s Code of Conduct, Sunil Healthcare has informed that the Trading Window for dealing in the securities of the Company will remain close for all the Directors, Promoters, Designated Employees and Connected Persons, with effect from July 01, 2022 till 48 hours after the declaration of Un-audited Financial results for the 01st quarter of financial year 2022-23 ended on June 30, 2022.
The above information is a part of company’s filings submitted to BSE.
